The IL-6/STAT3 signaling pathway has a key effect on breast cancer, enhancing cell proliferation, survival, and epithelial-mesenchymal transition, notably in triple-negative breast cancer (TNBC) [170]. This evidence concerns the gene STAT3 and breast cancer.